ArticlePloS one2026
Pyridoxine requirement of Pacific white shrimp (Penaeus vannamei) fed soybean meal based diet.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to determine the dietary pyridoxine requirement of Pacific white shrimp (Penaeus vannamei) fed a soybean meal-based diet. Seven experimental diets were prepared with graded pyridoxine supplementation at 0, 25, 50, 75, 100, 125, and 150 mg/kg diet (Con, P25, P50, P75, P100, P125, and P150, respectively). An additional negative control diet (Con-) was formulated by adding 0.4% tetracycline hydrochloride to verify microbial synthesis of pyridoxine. Juvenile shrimp (initial weight: 0.38 g) were randomly assigned to eight diets with quadruplicate tanks and fed the diets for 45 days. Growth performance and feed utilization were increased with dietary pyridoxine supplementation up to P75, whereas higher supplementation levels resulted in reduced responses (P < 0.001). Hepatopancreas pyridoxine concentration was gradually increased with increment in dietary pyridoxine levels (P < 0.001), reaching a plateau from P75 to P150, and remained lower in Con- group than in Con group. Non-specific immune response, including lysozyme, anti-protease and nitroblue tetrazolium activities and antioxidant capacities including superoxide dismutase and glutathione peroxidase were significantly increased by dietary pyridoxine supplementation (P < 0.05). Digestive enzyme activities, intestinal morphological indices, and hepatopancreatic F- and B-cell prevalence were also positively influenced by dietary pyridoxine supplementation (P < 0.05). Gene expression analysis showed increased transcription of cystathionine-γ-lyase, cystathionine-β-synthase, pyridoxal kinase, crustin, and penaeidine in response to pyridoxine supplementation. Based on a broken-line regression analysis of weight gain, the dietary pyridoxine requirement was estimated to be 69.0 mg/kg diet.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.